Ivonescimab Oncology Clinical Trials
1,600+ Patients Treated Across 19 Clinical Trials
Summit License Territories: United States, Canada, Europe and Japan
Akeso License Territories: Rest of World
All Akeso ivonescimab clinical trials are being conducted in China and/or Australia and are fully sponsored and managed by Akeso.
Learn more about our partnership with Akeso, Inc. here.
Filter
Summit Sponsored Ivonescimab Trials: Ivonescimab is currently being investigated in global Phase III clinical trials. Phase I and II were completed by our partner Akeso. This pipeline reflects clinical trials that have been announced.
Akeso Sponsored Ivonescimab Trials
All Akeso ivonescimab clinical trials are being conducted in China and/or Australia and are fully sponsored and managed by Akeso.
Ivonescimab is an investigational therapy that is not approved by any regulatory authority other than China’s National Medical Products Administration (NMPA).